 | • レポートコード：QYR2104Z1622 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：New Technology |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症体外診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（迅速診断検査（RDT）、酵素免疫測定法（ELISA）、中和アッセイ）、用途別市場規模（家庭、病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症体外診断の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症体外診断の種類別市場規模（迅速診断検査（RDT）、酵素免疫測定法（ELISA）、中和アッセイ） ・新型コロナウイルス感染症体外診断の用途別市場規模（家庭、病院、クリニック） ・新型コロナウイルス感染症体外診断の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症体外診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症体外診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症体外診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症体外診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cellex、Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Mayo Clinic Laboratories、Chembio Diagnostics、Mount Sinai Laboratory、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Innovita Biological Technology、Guangzhou Wondfo Biotech、Guangdong Hecin-Scientific、Dynamiker Biotechnology (Tianjin)、ADVAITE） ・結論 |
In 2021, the global COVID-19 In-Vitro Diagnostics market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 In-Vitro Diagnostics status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 In-Vitro Diagnostics development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global COVID-19 In-Vitro Diagnostics Scope and Market Size
COVID-19 In-Vitro Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 In-Vitro Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Rapid Diagnostic Test (RDT)
Enzyme Linked Immunosorbent Assay (ELISA)
Neutralization Assay
Segment by Application
Home
Hospital
Clinical
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type (2021-2027)
1.2.2 Rapid Diagnostic Test (RDT)
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Neutralization Assay
1.3 Market by Application
1.3.1 Global COVID-19 In-Vitro Diagnostics Market Share by Application (2021-2027)
1.3.2 Home
1.3.3 Hospital
1.3.4 Clinical
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global COVID-19 In-Vitro Diagnostics Market Size
2.2 COVID-19 In-Vitro Diagnostics Market Size by Regions
2.2.1 COVID-19 In-Vitro Diagnostics Growth Rate by Regions (2021-2027)
2.2.2 COVID-19 In-Vitro Diagnostics Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 COVID-19 In-Vitro Diagnostics Revenue by Players (2020-2021)
3.2 COVID-19 In-Vitro Diagnostics Key Players Headquaters and Area Served
3.3 Key Players COVID-19 In-Vitro Diagnostics Product/Solution/Service
3.4 Date of Enter into COVID-19 In-Vitro Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global COVID-19 In-Vitro Diagnostics Market Size by Type (2021-2027)
4.2 Global COVID-19 In-Vitro Diagnostics Market Size by Application (2021-2027)
5 North America
5.1 North America COVID-19 In-Vitro Diagnostics Market Forecast (2021-2027)
5.2 COVID-19 In-Vitro Diagnostics Key Players in North America
5.3 North America COVID-19 In-Vitro Diagnostics Market Size by Type
5.4 North America COVID-19 In-Vitro Diagnostics Market Size by Application
6 Europe
6.1 Europe COVID-19 In-Vitro Diagnostics Market Forecast (2021-2027)
6.2 COVID-19 In-Vitro Diagnostics Key Players in Europe
6.3 Europe COVID-19 In-Vitro Diagnostics Market Size by Type
6.4 Europe COVID-19 In-Vitro Diagnostics Market Size by Application
7 Japan
7.1 Japan COVID-19 In-Vitro Diagnostics Market Forecast (2021-2027)
7.2 COVID-19 In-Vitro Diagnostics Key Players in Europe
7.3 Japan COVID-19 In-Vitro Diagnostics Market Size by Type
7.4 Japan COVID-19 In-Vitro Diagnostics Market Size by Application
8 Rest of World
8.1 China
8.1.1 China COVID-19 In-Vitro Diagnostics Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia COVID-19 In-Vitro Diagnostics Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India COVID-19 In-Vitro Diagnostics Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Cellex
9.1.1 Cellex Company Details
9.1.2 Cellex Description and Business Overview
9.1.3 Cellex COVID-19 In-Vitro Diagnostics Introduction
9.1.4 Cellex Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.1.5 Cellex Recent Development
9.2 Abbott
9.2.1 Abbott Company Details
9.2.2 Abbott Description and Business Overview
9.2.3 Abbott COVID-19 In-Vitro Diagnostics Introduction
9.2.4 Abbott Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.2.5 Abbott Recent Development
9.3 Roche
9.3.1 Roche Company Details
9.3.2 Roche Description and Business Overview
9.3.3 Roche COVID-19 In-Vitro Diagnostics Introduction
9.3.4 Roche Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.3.5 Roche Recent Development
9.4 BioMedomics
9.4.1 BioMedomics Company Details
9.4.2 BioMedomics Description and Business Overview
9.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Introduction
9.4.4 BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.4.5 BioMedomics Recent Development
9.5 BD
9.5.1 BD Company Details
9.5.2 BD Description and Business Overview
9.5.3 BD COVID-19 In-Vitro Diagnostics Introduction
9.5.4 BD Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.5.5 BD Recent Development
9.6 Henry Schein
9.6.1 Henry Schein Company Details
9.6.2 Henry Schein Description and Business Overview
9.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Introduction
9.6.4 Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.6.5 Henry Schein Recent Development
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech Company Details
9.7.2 Safecare Bio-Tech Description and Business Overview
9.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Introduction
9.7.4 Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.7.5 Safecare Bio-Tech Recent Development
9.8 Mayo Clinic Laboratories
9.8.1 Mayo Clinic Laboratories Company Details
9.8.2 Mayo Clinic Laboratories Description and Business Overview
9.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Introduction
9.8.4 Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.8.5 Mayo Clinic Laboratories Recent Development
9.9 Chembio Diagnostics
9.9.1 Chembio Diagnostics Company Details
9.9.2 Chembio Diagnostics Description and Business Overview
9.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Introduction
9.9.4 Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.9.5 Chembio Diagnostics Recent Development
9.10 Mount Sinai Laboratory
9.10.1 Mount Sinai Laboratory Company Details
9.10.2 Mount Sinai Laboratory Description and Business Overview
9.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Introduction
9.10.4 Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.10.5 Mount Sinai Laboratory Recent Development
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics Company Details
9.11.2 Ortho Clinical Diagnostics Description and Business Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Introduction
9.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.11.5 Ortho Clinical Diagnostics Recent Development
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech Company Details
9.12.2 Zhejiang Orient Gene Biotech Description and Business Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Introduction
9.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.12.5 Zhejiang Orient Gene Biotech Recent Development
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology Company Details
9.13.2 Innovita Biological Technology Description and Business Overview
9.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Introduction
9.13.4 Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.13.5 Innovita Biological Technology Recent Development
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech Company Details
9.14.2 Guangzhou Wondfo Biotech Description and Business Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Introduction
9.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.14.5 Guangzhou Wondfo Biotech Recent Development
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific Company Details
9.15.2 Guangdong Hecin-Scientific Description and Business Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Introduction
9.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.15.5 Guangdong Hecin-Scientific Recent Development
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Company Details
9.16.2 Dynamiker Biotechnology (Tianjin) Description and Business Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Introduction
9.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
9.17 ADVAITE
9.17.1 ADVAITE Company Details
9.17.2 ADVAITE Description and Business Overview
9.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Introduction
9.17.4 ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business (2020-2021)
9.17.5 ADVAITE Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global COVID-19 In-Vitro Diagnostics Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Rapid Diagnostic Test (RDT)
Table 3. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 4. Key Players of Neutralization Assay
Table 5. Global COVID-19 In-Vitro Diagnostics Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global COVID-19 In-Vitro Diagnostics Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global COVID-19 In-Vitro Diagnostics Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global COVID-19 In-Vitro Diagnostics Revenue by Players (2020-2021) (US$ Million)
Table 11. Global COVID-19 In-Vitro Diagnostics Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players COVID-19 In-Vitro Diagnostics Product Solution and Service
Table 14. Date of Enter into COVID-19 In-Vitro Diagnostics Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global COVID-19 In-Vitro Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 17. Global COVID-19 In-Vitro Diagnostics Market Size Share by Type (2021-2027)
Table 18. Global COVID-19 In-Vitro Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 19. Global COVID-19 In-Vitro Diagnostics Market Size Share by Application (2021-2027)
Table 20. North America Key Players COVID-19 In-Vitro Diagnostics Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players COVID-19 In-Vitro Diagnostics Market Share (2020-2021)
Table 22. North America COVID-19 In-Vitro Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 23. North America COVID-19 In-Vitro Diagnostics Market Share by Type (2021-2027)
Table 24. North America COVID-19 In-Vitro Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 25. North America COVID-19 In-Vitro Diagnostics Market Share by Application (2021-2027)
Table 26. Europe Key Players COVID-19 In-Vitro Diagnostics Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players COVID-19 In-Vitro Diagnostics Market Share (2020-2021)
Table 28. Europe COVID-19 In-Vitro Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe COVID-19 In-Vitro Diagnostics Market Share by Type (2021-2027)
Table 30. Europe COVID-19 In-Vitro Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe COVID-19 In-Vitro Diagnostics Market Share by Application (2021-2027)
Table 32. Japan Key Players COVID-19 In-Vitro Diagnostics Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players COVID-19 In-Vitro Diagnostics Market Share (2020-2021)
Table 34. Japan COVID-19 In-Vitro Diagnostics Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan COVID-19 In-Vitro Diagnostics Market Share by Type (2021-2027)
Table 36. Japan COVID-19 In-Vitro Diagnostics Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan COVID-19 In-Vitro Diagnostics Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Cellex Company Details
Table 42. Cellex Description and Business Overview
Table 43. Cellex COVID-19 In-Vitro Diagnostics Product
Table 44. Cellex Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 45. Cellex Recent Development
Table 46. Abbott Company Details
Table 47. Abbott Description and Business Overview
Table 48. Abbott COVID-19 In-Vitro Diagnostics Product
Table 49. Abbott Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 50. Abbott Recent Development
Table 51. Roche Company Details
Table 52. Roche Description and Business Overview
Table 53. Roche COVID-19 In-Vitro Diagnostics Product
Table 54. Roche Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 55. Roche Recent Development
Table 56. BioMedomics Company Details
Table 57. BioMedomics Description and Business Overview
Table 58. BioMedomics COVID-19 In-Vitro Diagnostics Product
Table 59. BioMedomics Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 60. BioMedomics Recent Development
Table 61. BD Company Details
Table 62. BD Description and Business Overview
Table 63. BD COVID-19 In-Vitro Diagnostics Product
Table 64. BD Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 65. BD Recent Development
Table 66. Henry Schein Company Details
Table 67. Henry Schein Description and Business Overview
Table 68. Henry Schein COVID-19 In-Vitro Diagnostics Product
Table 69. Henry Schein Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 70. Henry Schein Recent Development
Table 71. Safecare Bio-Tech Company Details
Table 72. Safecare Bio-Tech Description and Business Overview
Table 73. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product
Table 74. Safecare Bio-Tech Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 75. Safecare Bio-Tech Recent Development
Table 76. Mayo Clinic Laboratories Company Details
Table 77. Mayo Clinic Laboratories Description and Business Overview
Table 78. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product
Table 79. Mayo Clinic Laboratories Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 80. Mayo Clinic Laboratories Recent Development
Table 81. Chembio Diagnostics Company Details
Table 82. Chembio Diagnostics Description and Business Overview
Table 83. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 84. Chembio Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 85. Chembio Diagnostics Recent Development
Table 86. Mount Sinai Laboratory Company Details
Table 87. Mount Sinai Laboratory Description and Business Overview
Table 88. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product
Table 89. Mount Sinai Laboratory Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 90. Mount Sinai Laboratory Recent Development
Table 91. Ortho Clinical Diagnostics Company Details
Table 92. Ortho Clinical Diagnostics Description and Business Overview
Table 93. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product
Table 94. Ortho Clinical Diagnostics Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 95. Ortho Clinical Diagnostics Recent Development
Table 96. Zhejiang Orient Gene Biotech Company Details
Table 97. Zhejiang Orient Gene Biotech Description and Business Overview
Table 98. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product
Table 99. Zhejiang Orient Gene Biotech Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 100. Zhejiang Orient Gene Biotech Recent Development
Table 101. Innovita Biological Technology Company Details
Table 102. Innovita Biological Technology Description and Business Overview
Table 103. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product
Table 104. Innovita Biological Technology Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 105. Innovita Biological Technology Recent Development
Table 106. Guangzhou Wondfo Biotech Company Details
Table 107. Guangzhou Wondfo Biotech Description and Business Overview
Table 108. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product
Table 109. Guangzhou Wondfo Biotech Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 110. Guangzhou Wondfo Biotech Recent Development
Table 111. Guangdong Hecin-Scientific Company Details
Table 112. Guangdong Hecin-Scientific Description and Business Overview
Table 113. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product
Table 114. Guangdong Hecin-Scientific Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 115. Guangdong Hecin-Scientific Recent Development
Table 116. Dynamiker Biotechnology (Tianjin) Company Details
Table 117. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 118. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product
Table 119. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 120. Dynamiker Biotechnology (Tianjin) Recent Development
Table 121. ADVAITE Company Details
Table 122. ADVAITE Description and Business Overview
Table 123. ADVAITE COVID-19 In-Vitro Diagnostics Product
Table 124. ADVAITE Revenue in COVID-19 In-Vitro Diagnostics Business 2020 and 2021
Table 125. ADVAITE Recent Development
Table 126. COVID-19 In-Vitro Diagnostics Market Trends
Table 127. COVID-19 In-Vitro Diagnostics Market Drivers
Table 128. COVID-19 In-Vitro Diagnostics Market Challenges
Table 129. COVID-19 In-Vitro Diagnostics Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 In-Vitro Diagnostics Market Share by Type in 2021 & 2027
Figure 2. Rapid Diagnostic Test (RDT) Features
Figure 3. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 4. Neutralization Assay Features
Figure 5. Global COVID-19 In-Vitro Diagnostics Market Share by Application in 2021 & 2027
Figure 6. Home Case Studies
Figure 7. Hospital Case Studies
Figure 8. Clinical Case Studies
Figure 9. COVID-19 In-Vitro Diagnostics Report Years Considered
Figure 10. Global COVID-19 In-Vitro Diagnostics Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 11. Global COVID-19 In-Vitro Diagnostics Market Share by Regions (2020-2027)
Figure 12. Global COVID-19 In-Vitro Diagnostics Market Share by Players in 2021
Figure 13. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Type (2021-2027)
Figure 14. Global COVID-19 In-Vitro Diagnostics Market Size Market Share by Application (2021-2027)
Figure 15. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Application in 2021
Figure 16. North America COVID-19 In-Vitro Diagnostics Market Size 2021-2027 (US$ Million)
Figure 17. Europe COVID-19 In-Vitro Diagnostics Market Size 2021-2027 (US$ Million)
Figure 18. Japan COVID-19 In-Vitro Diagnostics Market Size 2021-2027 (US$ Million)
Figure 19. COVID-19 In-Vitro Diagnostics Market Size in China (2021-2027) (US$ Million)
Figure 20. COVID-19 In-Vitro Diagnostics Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 21. COVID-19 In-Vitro Diagnostics Market Size in India (2021-2027) (US$ Million)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
世界の新型コロナウイルス感染症検査キット市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 Test Kits market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 Test Kits status, future forecast, growth opportunity, key market, and key players.…- 世界の新型コロナウイルス感染症検査キット市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 Test Kits market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 Test Kits status, future forecast, growth opportunity, key market, and key players.…
- 世界の新型コロナウイルス感染症診断検査市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 Diagnostic Tests market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 Diagnostic Tests status, future forecast, growth opportunity, key market, an…
- 世界の酵素免疫測定法（ELISA）市場規模・現状・予測（2021年-2027年） ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological sam…
- 世界の新型コロナウイルス感染症検査市場規模・現状・予測（2021年-2027年） In 2021, the global Covid-19 Testing market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Covid-19 Testing status, future forecast, growth opportunity, key market, and key players. The…